Acute Investment Advisory’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-14,354
Closed -$602K 21
2022
Q4
$602K Buy
+14,354
New +$581K 0.41% 13

Other funds holding VEA

Acute Investment Advisory's VEA Position: Q1 2023 in Review

Acute Investment Advisory sold out of Vanguard FTSE Developed Markets ETF (VEA) in Q1 2023, closing a stake of 14,354 shares — an estimated $602K sold.

Acute Investment Advisory first reported a position in VEA in Q4 2022 and held it in 1 quarter. The position peaked at $602K in Q4 2022. 1,880 funds tracked by Wall St. Rank hold VEA as of Q1 2023.

  • Acute Investment Advisory reported no remaining Vanguard FTSE Developed Markets ETF position as of Q1 2023 after selling out during the quarter.
  • Acute Investment Advisory sold 14,354 Vanguard FTSE Developed Markets ETF shares in Q1 2023, an estimated $602K.
  • Acute Investment Advisory first reported a position in Vanguard FTSE Developed Markets ETF in Q4 2022 and held it in 1 quarter.
  • Acute Investment Advisory's Vanguard FTSE Developed Markets ETF position peaked at $602K in Q4 2022.
  • 1,880 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q1 2023.

Based on Acute Investment Advisory's 13F filing for Q1 2023, filed 21 Apr 2023.